文献速递心脑血管急症

扩展时间窗内伴广泛梗死征象的缺血性卒中患者血栓切除术与功能结局的关联

Association of Thrombectomy With Functional Outcome for Patients With Ischemic Stroke Who Presented in the Extended Time Window With Extensive Signs of Infarction.
PubMed 文献 · JAMA Netw Open · 2022-10-03
一句话结论回顾性多中心队列显示,ASPECTS≤5、发病6–24小时行EVT成功再通与90天mRS≤3独立相关(aOR 4.39),获益见于≤17.6小时、ASPECTS 3–5。

该回顾性多中心队列纳入德国卒中登记-血管内治疗中ASPECTS≤5、发病6–24小时、2015年7月1日至2019年12月31日接受CT及EVT的285例患者(占5853例的5%)。90天mRS≤3者79例(27.7%),成功再通率75%(215/285),再通与mRS≤3独立相关(aOR 4.39;95%CI 1.79–10.72;P<.001)。逆概率加权分析中mTICI 2b/3与mRS≥3概率增加19%(95%CI 9%–29%;P<.001)相关。多变量logistic回归提示再通的治疗获益见于发病≤17.6小时且ASPECTS 3–5的患者;症状性颅内出血率6.3%(18/285)。作者鼓励当前随机临床试验纳入低ASPECTS患者,即使处于扩展时间窗。

要点

  • ASPECTS≤5、发病6–24小时行EVT的患者中,成功再通率75%(215/285),90天mRS≤3为27.7%(79/285)。
  • 成功再通与90天mRS≤3独立相关:aOR 4.39(95%CI 1.79–10.72;P<.001)。
  • 逆概率加权分析中mTICI 2b/3与mRS≥3概率增加19%(95%CI 9%–29%;P<.001)相关。
  • 多变量logistic回归提示再通获益见于发病≤17.6小时且ASPECTS 3–5的患者。
  • 症状性颅内出血率6.3%(18/285);作者鼓励随机临床试验纳入低ASPECTS的扩展时间窗患者。

适用人群与场景

  • 德国卒中登记-血管内治疗中ASPECTS≤5、发病6–24小时、接受CT及后续EVT的缺血性卒中患者,2015年7月1日至2019年12月31日。
  • 285例纳入分析(占5853例的5%);146例男性(51%);中位年龄73岁(IQR 62–81岁)。

诊断标准与关键阈值

  • ASPECTS≤5。
  • 发病6–24小时(扩展时间窗)。
  • 成功再通定义为mTICI评分2b或3。

研究设计与关键结果

  • 回顾性、多中心队列研究,纳入德国卒中登记-血管内治疗中285例ASPECTS≤5、发病6–24小时行EVT的患者。
  • 主要终点90天mRS≤3:79/285(27.7%)。
  • 成功再通率75%(215/285),与mRS≤3独立相关:aOR 4.39(95%CI 1.79–10.72;P<.001)。
  • 逆概率加权分析:mTICI 2b/3与mRS≥3概率增加19%(95%CI 9%–29%;P<.001)相关。
  • 多变量logistic回归提示再通的治疗获益见于发病≤17.6小时且ASPECTS 3–5。
  • 症状性颅内出血率6.3%(18/285)。

证据类型、等级与局限

  • 证据类型:回顾性、多中心队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,低ASPECTS且处于扩展时间窗的患者,血管再通与更好的功能结局相关,时间窗可达17.6小时且ASPECTS 3–5。
  • 作者鼓励当前随机临床试验纳入低ASPECTS患者,即使处于扩展时间窗。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Only limited data are available about a potential benefit associated with endovascular treatment (EVT) for patients with ischemic stroke presenting in the extended time window who also show signs of extensive infarction.

OBJECTIVE: To assess the association of recanalization after EVT with functional outcomes for patients with ischemic stroke presenting in the extended time window who also show signs of extensive infarction.

DESIGN, SETTING, AND PARTICIPANTS: This retrospective, multicenter cohort study included patients enrolled in the German Stroke Registry-Endovascular Treatment with an Alberta Stroke Program Early CT Score (ASPECTS) of 5 or less who presented between 6 and 24 hours after stroke onset and underwent computed tomography and subsequent EVT between July 1, 2015, and December 31, 2019.

MAIN OUTCOMES AND MEASURES: The primary end point was a modified Rankin Scale (mRS) score of 3 or less at day 90. The association between recanalization (defined as the occurrence of a modified Thrombolysis in Cerebral Infarction Scale score of 2b or 3) and outcome was assessed using logistic regression and inverse probability weighting analysis.

INTERVENTION: Endovascular treatment.

RESULTS: Of 5853 patients, 285 (5%; 146 men [51%]; median age, 73 years [IQR, 62-81 years]) met the inclusion criteria and were analyzed. Of these 285 patients, 79 (27.7%) had an mRS score of 3 or less at day 90. The rate of successful recanalization was 75% (215 of 285) and was independently associated with a higher probability of reaching an mRS score of 3 or less (adjusted odds ratio, 4.39; 95% CI, 1.79-10.72; P < .001). In inverse probability weighting analysis, a modified Thrombolysis in Cerebral Infarction Scale score of 2b or 3 was associated with a 19% increase (95% CI, 9%-29%; P < .001) in the probability for an mRS score of 3 or more. Multivariable logistic regression analysis suggested a significant treatment benefit associated with vessel recanalization in a time window of up to 17.6 hours and ASPECTS of 3 to 5. The rate of secondary symptomatic intracerebral hemorrhage was 6.3% (18 of 285).

CONCLUSIONS AND RELEVANCE: In this cohort study reflecting daily clinical practice, vessel recanalization for patients with a low ASPECTS and extended time window was associated with better functional outcomes in a time window up to 17.6 hours and ASPECTS of 3 to 5. The results of this study encourage current randomized clinical trials to enroll patients with a low ASPECTS, even within the extended time window.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Broocks G, Hanning U, Bechstein M, et al. Association of Thrombectomy With Functional Outcome for Patients With Ischemic Stroke Who Presented in the Extended Time Window With Extensive Signs of Infarction. JAMA Netw Open. 2022. PMID: 36239941. doi:10.1001/jamanetworkopen.2022.35733

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。